Skip to main content
QCLS
NASDAQ Life Sciences

Q/C Technologies Changes Auditor Amidst Prior Going Concern Warning

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$3.85
Mkt Cap
$30.236M
52W Low
$2.5
52W High
$44.4
Market data snapshot near publication time

summarizeSummary

Q/C Technologies dismissed its independent auditor, Stephano Slack LLC, and appointed Grassi & Co., CPAs, P.C., with the prior auditor's report for 2024 having included a going concern warning.


check_boxKey Events

  • Auditor Dismissal

    Stephano Slack LLC was dismissed as the independent registered public accounting firm on March 9, 2026.

  • Going Concern Warning Confirmed

    The dismissed auditor's report for the fiscal year ended December 31, 2024, included a paragraph stating substantial doubt about the company's ability to continue as a going concern.

  • No Disagreements Reported

    The company reported no disagreements or reportable events with the dismissed auditor, mitigating some concerns regarding the change.

  • New Auditor Appointed

    Grassi & Co., CPAs, P.C. was engaged as the new independent registered public accounting firm, effective immediately, to audit the company's financial statements for the year ended December 31, 2025.


auto_awesomeAnalysis

This 8-K discloses a change in Q/C Technologies' independent registered public accounting firm. While the company stated there were no disagreements or reportable events with the dismissed auditor, Stephano Slack LLC, their report for the fiscal year ended December 31, 2024, contained a "going concern" paragraph. This formal confirmation of substantial doubt about the company's ability to continue as a going concern, previously hinted at in the S-3 shelf registration, is a critical negative signal for investors, especially for a micro-cap company. The appointment of a new auditor, Grassi & Co., CPAs, P.C., is a necessary step, but the underlying financial distress remains a primary concern.

At the time of this filing, QCLS was trading at $3.85 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.2M. The 52-week trading range was $2.50 to $44.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed QCLS - Latest Insights

QCLS
Apr 29, 2026, 5:19 PM EDT
Filing Type: 10-K/A
Importance Score:
9
QCLS
Apr 15, 2026, 5:20 PM EDT
Filing Type: 10-K
Importance Score:
9
QCLS
Mar 13, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
QCLS
Feb 11, 2026, 5:17 PM EST
Filing Type: S-3
Importance Score:
8
QCLS
Jan 23, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
8